Dezocine prevents postoperative hyperalgesia in patients undergoing open abdominal surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004723

Enrollment

Unknown

Registered

2014-05-25

Start date

2014-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

group dezocine:intravenous injection of 0.15mg/kg dezocine

group control:intravenous injection of 0.9%NS

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. patients for elective open abdominal surgery, aged 18 to 64 years; 2. ASA I-II; 3. not diabetes or severe arterial hypertension; 4. not end stage cancer.

Exclusion criteria

Exclusion criteria: 1. patients with chronic pain; 2. patients with chronic inflammatory disease; 3. opioid addiction, tolerance or preoperative administration of opioids; 4. anticipated ICU stay; 5. drugs or alcohol abuse; 6. psychosis; 7. obesity; 8. patients who refuse to enter the trial.

Design outcomes

Primary

Measure	Time frame
PCA consumption;	—

Countries

China

Contacts

Public ContactYU FANG

Shanghai Renji Hospital

stephaniefyu@gmail.com+86 13472763903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026